COVID-19: challenges and opportunities for educators and generation Z learners
AL Marshall… - Mayo Clinic …, 2020 - mayoclinicproceedings.org
The coronavirus disease 2019 (COVID-19) pandemic has and will continue to have a dramatic
effect on the world and how we function as communities and societies. One area that has …
effect on the world and how we function as communities and societies. One area that has …
Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic
…, LJ Oyen, DE Houghton, AL Marshall… - Mayo Clinic …, 2020 - Elsevier
A higher risk of thrombosis has been described as a prominent feature of coronavirus disease
2019 (COVID-19). This systematic review synthesizes current data on thrombosis risk, …
2019 (COVID-19). This systematic review synthesizes current data on thrombosis risk, …
The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample–based analysis
AL Marshall, U Durani, A Bartley, CE Hagen… - American journal of …, 2017 - Elsevier
… Author links open overlay panel Ariela L. Marshall MD a d , Urshila Durani MD c , Adam
Bartley MS b , Clinton E. Hagen MS b , Aneel Ashrani MD, MS a d , Carl Rose MD e , Ronald S. …
Bartley MS b , Clinton E. Hagen MS b , Aneel Ashrani MD, MS a d , Carl Rose MD e , Ronald S. …
Genetic susceptibility to lung cancer—light at the end of the tunnel?
AL Marshall, DC Christiani - Carcinogenesis, 2013 - academic.oup.com
Lung cancer is one of the most common and deadliest cancers in the world. The major socio-environmental
risk factor involved in the development of lung cancer is cigarette smoking. …
risk factor involved in the development of lung cancer is cigarette smoking. …
Disparities in burnout and satisfaction with work–life integration in US physicians by gender and practice setting
AL Marshall, LN Dyrbye, TD Shanafelt… - Academic …, 2020 - journals.lww.com
Purpose To explore the interaction between practice setting (academic practice [AP], private
practice [PP]) and gender in relation to physician burnout and satisfaction with work–life …
practice [PP]) and gender in relation to physician burnout and satisfaction with work–life …
Evaluating unconscious bias: speaker introductions at an international oncology conference
…, MC Murphy, S Jain, AL Marshall… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE In a professional setting, the introduction of female speakers without their
professional title may have an impact on the public’s perception of the female speaker. We …
professional title may have an impact on the public’s perception of the female speaker. We …
Thrombotic microangiopathy care pathway: a consensus statement for the Mayo clinic complement alternative Pathway-Thrombotic microangiopathy (CAP-TMA) …
…, RS Abraham, H Amer, WJ Hogan, AL Marshall… - Mayo Clinic …, 2016 - Elsevier
Thrombotic microangiopathies (TMAs) comprise a heterogeneous set of conditions linked
by a common histopathologic finding of endothelial damage resulting in microvascular …
by a common histopathologic finding of endothelial damage resulting in microvascular …
Physician fertility: a call to action
Infertility is more prevalent in female physicians than in the US general population. While
pregnancy and its potential medical and career development consequences among physicians …
pregnancy and its potential medical and career development consequences among physicians …
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
Objectives Genetic variations or polymorphisms within genes of the nucleotide excision repair
(NER) pathway alter DNA repair capacity. Reduced DNA repair (NER) capacity may result …
(NER) pathway alter DNA repair capacity. Reduced DNA repair (NER) capacity may result …
[HTML][HTML] The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors
H Al-Samkari, AL Marshall, K Goodarzi, DJ Kuter - Haematologica, 2018 - ncbi.nlm.nih.gov
< 75x109/L, a median duration of 7 days of romiplostim therapy (a single dose) was required
to achieve a platelet count≥ 75x109/L. Similarly, a median of only 7 days of therapy was …
to achieve a platelet count≥ 75x109/L. Similarly, a median of only 7 days of therapy was …